Search Results - "PENACK, Olaf"

Refine Results
  1. 1
  2. 2
  3. 3

    Acute Graft-versus-Host-Disease Other Than Typical Targets: Between Myths and Facts by Mariotti, Jacopo, Penack, Olaf, Castagna, Luca

    Published in Transplantation and cellular therapy (01-02-2021)
    “…•Skin, liver, and gut are not the only organs involved in acute graft-versus-host disease (aGVHD).•Kidney, bone marrow, central nervous system, and lung may be…”
    Get full text
    Journal Article
  4. 4

    EASIX and mortality after allogeneic stem cell transplantation by Luft, Thomas, Benner, Axel, Terzer, Tobias, Jodele, Sonata, Dandoy, Christopher E., Storb, Rainer, Kordelas, Lambros, Beelen, Dietrich, Gooley, Ted, Sandmaier, Brenda M., Sorror, Mohamed, Zeisbrich, Markus, Radujkovic, Aleksandar, Dreger, Peter, Penack, Olaf

    Published in Bone marrow transplantation (Basingstoke) (01-03-2020)
    “…Allogeneic stem cell transplantation (alloSCT) is an effective immunotherapy in patients with hematological malignancies. Endothelial dysfunction was linked to…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel by Jiang, Sihe, Penack, Olaf, Terzer, Tobias, Schult, David, Majer-Lauterbach, Joshua, Radujkovic, Aleksandar, Blau, Igor W, Bullinger, Lars, Müller-Tidow, Carsten, Dreger, Peter, Luft, Thomas

    Published in Haematologica (Roma) (01-02-2021)
    “…No biomarker panel is established for prediction of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD), a major complication of allogeneic stem…”
    Get full text
    Journal Article
  10. 10

    Management of complications of chimeric antigen receptor T-cell therapy: a report by the European Society of Blood and Marrow Transplantation by Penack, Olaf, Peczynski, Christophe, Boreland, William, Wolff, Daniel, Moiseev, Ivan, Schoemans, Hélène, Koenecke, Christian, Graham, Charlotte, Peric, Zinaida

    Published in Haematologica (Roma) (30-05-2024)
    “…CAR-T cells are in standard clinical use to treat relapsed or refractory hematologic malignancies, such as non-Hodgkin's lymphoma, multiple myeloma and acute…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy-A Cohort Study by Korell, Felix, Penack, Olaf, Mattie, Mike, Schreck, Nicholas, Benner, Axel, Krzykalla, Julia, Wang, Zixing, Schmitt, Michael, Bullinger, Lars, Müller-Tidow, Carsten, Dreger, Peter, Luft, Thomas

    Published in Frontiers in immunology (08-04-2022)
    “…Endothelial dysfunction is associated with two main complications of chimeric antigen receptor T (CAR-T) cell therapy, cytokine release syndrome (CRS) and…”
    Get full text
    Journal Article
  20. 20

    Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors by Penack, Olaf, Holler, Ernst, van den Brink, Marcel R.M.

    Published in Blood (11-03-2010)
    “…Acute graft-versus-host disease (GVHD) remains the major obstacle to a more favorable therapeutic outcome of allogeneic hematopoietic stem cell transplantation…”
    Get full text
    Journal Article